A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects.

Chaoying HuWanling SunYuanyuan WuJunlong HuangXiangrong ZhangLan Zhang

Published in: Clinical therapeutics (2024)

clinicaltrials.gov identifier: NCT03657238.

Keyphrases

open label

drug delivery

clinical trial

double blind